Posted on January 11, 2021 by Aaron Warwick
Milestone Scientific (MLSS), a developer of computerized drug delivery instruments, continues to impress in the new year. Today, MLSS announced a distribution agreement with Bitmedical AG to distribute MLSS’s CompuFlo and CathCheck products, and their related consumables, throughout Switzerland and Austria. This announcement follows on the heels of last week’s announcement that MLSS signed its first hospital deal for CompuFlo with the University of Texas Medical Branch at Galveston.
One of the most interesting aspects of today’s announcement was the commentary provided by MLSS President Arjan Haverhals: “We are pleased to enter into this distribution agreement with Bitmedical in such a short period of time since our first contact in November of 2020, which we believe illustrates their confidence in the market potential for our instruments. Bitmedical is an ideal distribution partner as its principals have extensive expertise and proven track records launching new medical devices in Austria and Switzerland.”
Of further note was an additional comment by Haverhals: “Besides his current role as CEO of Bitmedical, Hansruedi Muehlegg has a direct anesthesia background as a Clinical Registered Nurse Anesthetist, and thus is very familiar with the challenges associated with epidural procedures.
For his part, Muehlegg noted: “We are impressed with Milestone Scientific’s CompuFlo Epidural System following extensive due diligence and positive feedback from end users prior to entering this agreement. Our analysis found CompuFlo’s objective, quantifiable and real-time pressure detection provides a measure of safety not currently available in epidural anesthesia.”
Disclosure: I am long MLSS and may buy or sell shares at any time.